carvacrol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashraf, GM; Javed, H; Jha, NK; Mohamed Fizur, NM; Ojha, S | 1 |
| Chun, YL; Huh, Y; Jung, J; Kim, M; Kim, N; Kim, YH; Park, C; Yang, H | 1 |
1 review(s) available for carvacrol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
Topics: Alzheimer Disease; Antioxidants; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2023 |
1 other study(ies) available for carvacrol and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Carvacrol effectively protects demyelination by suppressing transient receptor potential melastatin 7 (TRPM7) in Schwann cells.
Topics: Cells, Cultured; Cymenes; Demyelinating Diseases; Humans; Neurodegenerative Diseases; Origanum; Phytotherapy; Protein Serine-Threonine Kinases; Schwann Cells; Sciatic Nerve; TRPM Cation Channels; Up-Regulation | 2020 |